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In the current study Indomethacin (IM) fast dissolving 
tablets (FDTs) were prepared by direct compression technique in 
order to enhance its dissolution rate. The tablets were formulated 
using two different approaches; super-disintegration and efferves-
cence. A combination formulation of above approaches was also 
developed to further improve its properties. The super-disintegrants 
used in the formulae were sodium starch glycolate (Primogel), 
cross-povidone (Kollidon) and cross-carmellose (Ac-di-sol). Sodium 
bicarbonate and citric acid combination was employed as effervescent 
ingredients. The prepared powder mixtures of IM were subjected to 
evaluation of various pre-compression parameters and tablets were 
evaluated for weight variation, dimension, hardness, friability, drug 
content, disintegration, wetting time, uniformity of dispersion, in 
vitro drug release and stability studies. The FT-IR spectra shown 
there are no interaction between of IM with excipient. The results 
of pre-compression studies indicate acceptable flow property for all 
the powder mixtures. The data of weight variation, dimension, 
hardness, friability, uniformity of dispersion and drug content studies 
were within the official limits. The wetting time and disintegration 
time decreases considerably with the increase in super-disintegrants 
amount. By using the combination approach, the disintegration and 
wetting time further decreased. In vitro dissolution studies were 
carried out using phosphate buffer pH 6.8 as dissolution medium 
for 60min and observed that formulation IF9, among super-
disintegration approach, released highest percentage (97.13±2.09) 
of IM. In vitro drug release was highest (98.54±2.89) at 60 min for 
formulation IF11, when all the formulations were taken into 
consideration. The stability study was performed on the promised 
formulation IF11 at 40±2oC/ 75±5% RH for 3 months and the 
results indicated that there were no significant changes in aforesaid 
tablet properties. 
 




Oral drug delivery is the most widely 
used route of drug administration among all the 
routes that have been explored for the systemic 
delivery via various pharmaceutical products of 
different dosage forms (Ghosh et al., 2005) 
because of its distinct advantages of ease of 
administration, improved patient compliance, 
flexibility in designing the dosage form, least 
sterility requirements and avoidance of pain 
compared to parenteral route (Krishnaiah et al., 
2002, Saurabh et al., 2011, Prabhu et al., 2011, 
Bhalla et al., 2012). Tablets and capsules are the 
most popular solid dosage forms administered 
orally. It is estimated that 50 % of the 
population is affected by dysphasia (difficulty in 
swallowing), which is the major limitation 
associated with solid dosage forms such as 
tablet (Barnhart et al., 2007). In addition, it may 
pose problem for pediatric and geriatric 
patients who find swallowing difficult and for 
the treatment of some patients when water is 
not available in the case of motion sickness 
(kinetosis) and sudden attack of coughing 
during the common cold and bronchitis 
(Gryczke et al., 2011, Tritthart et al., 2001). This 
can be resolved by the preparation of rapidly 
dispersing or dissolving oral forms that 
combines both the properties of liquid and 
tablet dosage forms (Habibh et al., 2000). 
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The orally disintegrating tablets are also 
called as orodispersible tablets (ODTs), quick 
disintegrating tablets, fast disintegrating tablets, 
fast dissolving tablets. United States Food and 
Drug Administration (US FDA) defined ODTs 
as “a solid dosage form containing medicinal 
substances or active ingredient which 
disintegrates rapidly usually within a matter of 
seconds when placed upon the tongue”. US 
FDA further defines ODTs as solid oral 
preparations that disintegrate rapidly in the oral 
cavity with an in-vitro disintegration time of 
approximately 30 s or less (Guidance for 
industry, 2008). In addition, ODTs should  
have  an  acceptable  taste  and  very  short  
disintegration  time, generally from few seconds 
to about a minutes,  in  the  mouth. It is always 
a challenge to prepare ODTs having short oral 
disintegration  time  as it is with  positive  
correlation  with  the mechanical  strength  of  
the  tablets (Szakonyi et al., 2013).  
Indomethacin belongs to non-steroidal 
anti-inflammatory drug class, which is used to 
reduce fever, pain and inflammation associated 
with musculo-skeletal and joint disorders 
including ankylosing spondolysis, rheumatoid 
arthritis, osteoarthitis and acute gout (Shen, 
1982, Kulmacz, 1989, Nunchanit et al., 2013). It 
is described as Class II (poorly aqueous 
solubility and high permeability) drug in BCS. 
So, it is proposed to develop ODT dosage 
form of indomethacin to increase its solubility 
and subsequently bioavailability.  
In the present investigation FDTs of IM 
were prepared by direct compression method 
using two approaches namely; super-
disintegration and effervescence. The physico-
chemical properties of the particular 
disintegrants determine the disintegration 
mechanism followed by the disintegration time 
(Douroumis, 2007). The super-disintegrants 
used were Primogel, Kollidon and Ac-di-sol. In 
case of effervescence approach, sodium 
bicarbonate and citric acid were incorporated in 
tablet formulation as effervescent ingredients. 
Various powder mixtures underwent various 
pre-compression tests such as FT-IR studies, 
bulk and tapped density, angle of repose, Carr’s 
index and Hausner ratio. The prepared tablets 
were evaluated for various physical parameters 
and in-vitro disintegration and dissolution tests. 
 
MATERIAL AND METHODS 
Indomethacin, Cross-carmellose sodium 
(Ac-di-sol), Cross-povidone (Kollidon) and 
Aerosil were suppied by Yarrow Chem 
Products, Mumbai. Lactose monohydrate, 
mannitol, menthol, magnesium stearate and 
sodium saccharin obtained from LOBA Chemie 
PVt. Ltd., Mumbai. Sodium starch glycolate 
(Primogel) and microcrystalline cellulose 
(Avicel PH101) were purchased from CDH, 
New Delhi. All other chemicals used 
throughout the research were of analytical 
grades.  
 
Preparation of tablets 
Fast dissolving tablets of IM were 
prepared by direct compression technique using 
two different approaches such as super-
disintegration and effervescence and also a 
formulation containing their combination. The 
formulae for all batches are represented in table 
I. Indomethacin dose was 150mg and the total 
weight of tablet was fixed at 350mg. Avicel 
PH102 and mannitol were used as directly 
compressible material and diluent, respectively. 
Mentioned quantities of drug and other 
ingredients were weighed accurately and passed 
through mesh no # 60 before mixing. All the 
above ingredients were transferred to mortar 
and mixed thoroughly for 15 minutes except 
magnesium stearate, which was added and 
mixed for 5min before compression by 
spatulation method. The above powder mixture 
were compressed into tablets using ten station 
minipress punching machine (Rimek 
Compression Machine) equipped with flatefaced 
9.0mm punch.  For tablets prepared by 
effervescent technique, sodium bicarbonate and 
citric acid were accurately weighed and 
preheated to 80ºC to obtain a constant weight 
before mixing with other ingredients (Kadria et 
al., 2013).   
 
Drug–Excipient Interaction Study 
Drug-excipient interaction study was 
carried out by FT-IR technique (FTIR-1700, 
Shimadzu, Kyoto, Japan) in order to determine 
the interaction of IM with the excipient used in 
the formulations. The pure drug and the 
physical mixture (1:1) of drug with MCC, 
Primogel, Kollidon and Ac-di-sol were scanned 
in KBr discs in the range of 4000–400 cm–1. 
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Micromeritics study 
Bulk density and Tapped density 
Bulk density determined by filling fixed 
amount (10gm) of powder blends into a 
volumetric flask (50mL) followed by recording 
its volume. Tapped density was determined in a 
graduated measuring cylinder after subjecting to 
100 taps fixed over a digital tapped density 
apparatus (Electrolab-ETP-1020) (Peppas et al., 
1985).  
 
Angle of repose 
Angle of repose of powder blends were 
measured by fixed height cone method or 
funnel method. The height of the funnel was 
adjusted in such a way that the tip of the funnel 
just touched the tip of the heap of the powder 
blends (4cm). Accurately weight amount of 
powder mixtures were taken in the above 
funnel and allowed to flow through the funnel 
freely. The height and radius were measured 
and the angle of repose were calculated 
(Cooper et al., 1986) 
 
Carr’s index and Hausner ratio 
Compressibility index and Hausner ratio 
for all powder blends were determined by 
following equations (Wells, 2002) 
 
TBD-LBD 









Post-compression parameters (Goto et 
al., 2004, Wu et al., 2009) 
Dimension 
Thickness and diameter were measured 
for five tablets by using Vernier calipers and the 
average was expressed in mm. 
 
Weight uniformity 
Twenty tablets were weighed individually 
using electronic balance (Shimadzu Corporation-
BL-220H) and then the average tablet weight 
was calculated. The percentage variation of 




Hardness was determined by randomly 
taking 10 tablets from each batch, using 
Monsanto hardness tester (Electrolab Pvt. Ltd., 
India) and the average diametric compression 




The friability of a sample of 10 tablets 
was measured using Roche friabilator (Electro 
lab, EF-2, Mumbai, India). The weight of 10 
tablets was recorded and was placed in drum of 
a Roche Friabilator, which was run at 25rpm 




IF1 IF2 IF3 IF4 IF5 IF6 IF7 IF8 IF9 IF10 IF11 
Indomethacin 150 150 150 150 150 150 150 150 150 150 150 
MCC 120 120 120 120 120 120 120 120 120 120 120 
Mannitol 53 59 45 53 59 45 53 59 45 12 --- 
Primogel 4 8 12 ---- ---- ---- ---- ---- ---- --- --- 
Kollidon ---- ---- ---- 4 8 12 ---- ---- ---- --- --- 
Ac-di-sol ---- ---- ---- ---- ---- ---- 4 8 12 --- 12 
Sodium 
bicarbonate 
--- --- ---- --- --- --- --- --- --- 25 25 
Citric acid --- --- --- --- --- --- --- --- --- 20 20 
Aerosil 4 4 4 4 4 4 4 4 4 4 4 
Sod. saccharin 10 10 10 10 10 10 10 10 10 10 10 
Mag. stearate 4 4 4 4 4 4 4 4 4 4 4 
Menthol 5 5 5 5 5 5 5 5 5 5 5 
 
* Total weight of tablet = 350 mg 
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for 4min. Tablets were reweighed after 




Disintegration test was carried out by 
using disintegration apparatus (ED-2L 
Electrolab). One tablet was placed in each of the 
six tubes of the basket assembly and was dipped 
in phosphate buffer pH 6.8 maintained at 
37±1ºC. The time in seconds taken for complete 
disintegration of tablets were recorded. 
 
Drug content 
Five tablets were taken and crushed in 
mortar. From this the amount of powder 
equivalent to 25mg of IM was transferred in to 
a conical flask containing 25ml of methanol.  
The absorbance was measured at 320nm after 
suitable dilution. 
 
Wetting time and Water absorption ratio 
The method used a piece of tissue paper 
folded twice was placed in a petri dish with a 
10cm diameter containing 10 ml of phosphate 
buffer pH 6.8. A tablet was placed on the tissue 
paper and the time required for complete 
wetting was recorded (Tejvir et al., 2011). Three 
trials for each batch were performed. Water 
absorption ratio was calculated employing 
following equation; 
WA  
Where, Wa and Wb are  the weight after and 
before water  absorption, respectively 
 
Dispersion 
Uniformity of dispersion was performed 
to determine the dispersion of the drug in the 
water uniformly. Two tablets were placed in 
100mL of water in a 250mL beaker and were 
stirred uniformly for a minute and then the 
solution was passes through the 710µm mesh 
or sieve no 22 # see that whether all the 
contents of the mixture pass through the sieve 
without leaving a residue on the mesh (Indian 
Pharmacopeia, 2010). 
 
In-vitro dissolution studies 
Dissolution test for prepared FDTs of 
IM were performed using USP type II 
apparatus (Electrolab TDT-08L, Mumbai). 
Phosphate buffer pH 6.8 (900ml) maintain at 
37±0.5°C was used as dissolution medium and 
the rotational speed of paddle was kept at 50 
rpm. Five milliliter of aliquots were withdrawn 
at 5, 10, 15, 30 and 60min and replaced with 
fresh dissolution media maintained at same 
temperature. The samples were passed through 
membrane filter (pore size, 0.45μm) and 
assayed immediately for IM content by UV 
spectrophotometer at 320nm (UV-1800, 
Shimadzu, Japan). This test was performed on 
6 tablets and mean ± SD calculated. 
 
Statistical analysis 
One way analysis of variance (One-way 
ANOVA) with student Newman Keuls 
multiple comparison tests was used to perform 
statistical significant differences between 
various in vitro drug release data at 95% 
confidential level (5% significance level). It was 
carried out employing 30 days trial version of 
GraphPad Instat software. 
 
Stability studies  
Short-term stability study was performed 
on the promising formulation (IF11) for a 
period of 3 months at accelerated condition 
(40o± 2o C/ 75±5% RH). Fixed number of 
tablets (25) were packed in amber colored 
rubber stoppered vials and placed in stability 
chamber (JRIC 11, Osworld, Mumbai) 
maintained at above condition. At intervals of 1 
month, the tablets were visually examined for 
any physical changes; changes in drug content 
and at the end of three months, tablets were 
withdrawn and evaluated for in vitro drug 
release (Swamy et al., 2011).  
 
RESULT AND DISCUSSIONS 
Fast dissolving tablets of IM were 
prepared by direct compression technique, 
which is said to be most simple, less time 
consuming and economical. Two approaches 
such as super-disintegration and effervescence 
were employed for fast dissolving of tablets. 
Mannitol was incorporated into tablet 
formulation for multiple purposes such as 
cooling effect due to negative heat of solution, 
non-hygroscopic, good aqueous solubility and 
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Drug-excipient interaction study 
FT-IR spectra of pure IM, IM with 
Avicel, Primogel, Kollidon and Ac-di-sol      
were determined by KBr disc method and     
are presented in figure 1. The characteristic 
peaks of  IM were at 1067.96cm-1, 1223.57cm-1,  
1291.34cm-1, 1691.86cm-1 and 1718.68cm-1. 
There was no such significant shift in the 
position of major peaks in the above physical 
mixtures indicating that no chemical reaction or 





Figure 1. FT-IR spectra of pure drug and drug with Avicel, Primogel, Kollidon and Ac-di-sol.  
 














IF1 0.57±0.90 0.84±0.78 14.65±0.43 28.94±0.74 1.48±0.67 
IF2 0.55±0.67 0.85±0.65 17.53±0.70 27.94±0.36 1.48±0.87 
IF3 0.54±0.67 0.84±0.89 15.92±0.13 26.14±0.65 1.45±0.25 
IF4 0.57±0.21 0.85±0.56 16.46±0.31 29.94±0.73 1.46±0.19 
IF5 0.52±0.26 0.85±0.16 12.67±0.54 27.94±0.37 1.48±0.11 
IF6 0.57±0.29 0.84±0.76 15.09±0.78 26.14±0.62 1.45±0.04 
IF7 0.54±0.22 0.84±0.55 12.50±0.66 25.14±0.40 1.47±0.94 
IF8 0.51±0.35 0.84±0.52 15.56±0.52 26.19±0.56 1.48±0.33 
IF9 0.53±0.54 0.85±0.68 14.24±0.66 24.94±0.24 1.47±0.78 
IF10 0.51±0.35 0.81±0.52 15.56±0.52 27.39±0.56 1.41±0.53 
IF11 0.51±0.54 0.88±0.68 13.73±0.36 25.54±0.27 1.37±0.73 
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Micromeretrics studies 
Powder mixtures of all the formulation 
were evaluated for various physical 
characteristics and the values were presented in 
table II. The values of bulk and tapped density 
are indicative of good packing character. Angle 
of repose gives qualitative and quantitative 
assessment of internal cohesive and frictional 
force. Values for angle of repose for all the 
formulations were ranged between 24.94±0.24 
and 29.94±0.73º, which indicated good flow 
properties (Martin et al., 2002). Further, Carr’s 
index for all the formulation was found to be 
below 18 %. This indicates acceptable flow 
properties (Wells, 2002). Hausner ratio values 
for all the formulations were ranging from 
1.37±0.73 to 1.48±0.87, indicating desirable 
flow properties. Hence, the prepared blends 
possessed good flow properties and these can 
be used to manufacture tablets by direct 
compression method.  
 
Table III. Comparison of physical parameters of all the of tablet formulations 
 
No A B C D E F G H I J 
IF1 348±0.45 3.2±0.67 5.84±0.77 9.0 0.40 92 98.63±0.99 58 16.9 passes 
IF2 348±0.56 3.1±0.86 5.85±1.76 9.0 0.54 69 97.53±0.59 46 31.5 Passes 
IF3 347±0.76 3.1±0.65 5.85±1.00 9.0 0.66 56  97.33±0.78 25 59.5 Passes 
IF4 348±1.20 3.2±0.34 5.84±0.76 9.0 0.40 83  98.44±0.43 42 34.1 Passes 
IF5 348±0.65 3.0±0.56 5.84±0.87 9.0 0.17 68  98.16±1.07 31 47.2 Passes 
IF6 347±0.67 3.1±0.73 5.86±0.99 9.0 0.55 51  99.72±0.98 18 53.6 Passes 
IF7 349±0.98 3.0±1.10 5.85±0.34 9.0 0.20 78  96.47±0.65 35 30.2 Passes 
IF8 348±0.52 3.1±0.23 5.85±0.55 9.0 0.18 58 97.65±0.32 27 39.8 Passes 
IF9 348±0.56 3.0±0.41 5.84±0.36 9.0 0.22 44 98.21±0.61 19 52.8 Passes 
IF10 349±0.46 3.2±0.45 5.84±0.34 9.0 0.24 56 99.43±0.78 23 23.8 Passes 
IF11 347±0.88 3.3±1.0 5.85±0.29 9.0 0.28 38 98.87±0.65 17 61.5 Passes 
 
A=Weight (mean±SD, mg) n=20; B=Hardness (mean±SD, kg/cm2) n=10; C=Thickness (mean±SD, mm) 
n=20; D=Diameter (mean±SD, mm) n=20; E=Diameter (mean±SD, mm) n=20; F=Diameter (mean±SD, 
mm) (n=6); G= Drug Content (%)(n=10). ; H=Wetting time (sec) (n=6); I=Water absorption  ratio (n=6); 
J=Uniformity of dispersion (n=2). 
 
 
Table IV. Comparison of physical parameters for optimized formulation IF11 before, during and 
after 3 months of stability study 
 
40o± 2oC/ 75±5% RH 
Parameters 
IF11 
Initial At the end 
of 1st  month 
At the end of 
2nd  month 
At the end 
of 3rd  month 
Thickness (mm) 5.85±0.29 5.87±0.23 5.88±0.31 5.91±0.04 
Diameter (mm) 9.0 9.0 9.07 9.1 
Hardness (kg/cm2) 3.3±1.0 3.2±1.0 3.3±1.0 3.1±1.0 
Friability (%) 0.28 0.28 0.29 0.30 
Weight Variation (mg) 347±0.88 348±0.27 348±0.09 349±0.7 
Content Uniformity 98.87±0.65 98.27±0.12 98.07±0.64 97.77±0.75 
Disintegration time 38 sec 35 sec 34 sec 34 sec 




--- --- 99.04±1.79 
 
*Mean ± SD, n = 10 (hardness, friability and drug content studies), n = 20 (thickness, diameter and weight 
variation), n = 6 (disintegration and in-vitro drug release)  
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Figure 3. Dissolution profile of formulations from IF9 to IF11 (mean ± SD, n = 6) 
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Physical parameters of tablets 
All the tablet formulations were 
processed under similar condition to avoid any 
type of variation in physical tests and the results 
are given in the table III. The average 
percentages of weight variation for all the tablet 
formulations were within the acceptable limit. 
All the formulation shows uniform diameter 
and the percentage of thickness deviations were 
within the limit. Hardness of all the batches of 
tablets was above 3kg/cm2. Hardness is not an 
absolute indicator of tablet strength. So, 
friability was measured by taking 10 tablets in 
Roche friabilator from each batch and the 
values demonstrates that the friability of all the 
batches were within the official limit (≤1%) 
(Swamy et al., 2011, United States Pharmacopeia, 
2009). The hardness and friability values indicate 
good mechanical strength to withstand 
handling and transportation. The drug content 
uniformity of FDTs was between 96.4±0.65 
and 99.43±0.78. 
The wetting and disintegration time, for 
formulations contaning Primogel as super-
disintegrants, decreases with increase in super-
disintegrant amount per tablet from 4mg in IF1 
to 12mg in IF3. Same trend was also observed in 
case of formulations containg Kollidon and Ac-
di-sol as super-disintegrants. This was attributed 
to the fact that more the amount of super-
disintegrant higher is the water absorption and 
swelling, resulting in rapid wetting and 
disintegration of tablets. The disintegration time 
for all the batches of tablets were well below the 
accepted official limit of 3min. The least values 
for wetting time (17s) and disintegration time 
(38s) were shown by formulation IF11. This may 
be due to the combination of super-
disintegration and efferevescence approaches. 
Uniformity of dispersion is performrd to predict 
how well the tablet is going to disintegrats in 
mouth without any particulate matter above size 
710 nm. All the dveloped tablet batches passed 
the test.  
 
In vitro dissolution studies 
In-vitro dissolution studies of all the 
FDT formulations were carried out for 60min 
in USP dissolution apparatus II containing 
phosphate buffer pH 6.8 and data were 
represented in Figure 2 & 3. In addition to two 
approaches namely super-disintegration and 
effervescence, a combination approach 
containing both the ingredients was used. The 
order of increased drug dissolution using above 
approaches was as follows; combination > 
super-disintegration > effervescence.  
In case of super-disintegration, the 
cumulative percentage of drug release for 
formulation IF1-IF9 increases with the increase 
in super-disintegrants amount from 4mg to 12 
mg per tablet. It is based on the fact that higher 
the concentration of super-disintegrants more 
rapid is the disintegration followed by drug 
release. Among different super-disintegrants 
used Ac-di-sol shown highest percentage of 
drug release after 60min of dissolution at same 
concentration followed by Primogel and 
Kollidon, which is in accordance with Gryczke 
et al., 2011. This result was attributed to 
different disintegration mechanisms of selected 
super-disintegrants. Primogel and Kollidon act 
by swelling by absorbing water leading to 
separation of tablet into particles. In case of 
Ac-di-sol the mechanism of action is wicking 
via capillary action followed by disruption of 
the inter-particular matrix bonds resulting in 
the tablet disintegration (Kottke et al., Be et al., 
1999). Formulation IF9 containing 12mg of 
Ac-di-sol released highest cumulative percentage 
of drug (97.13±2.09%) at 60min.  
For formulation based on effervescence 
principle, provides a cumulative percentage of 
drug release of 89.41±1.21% after 1 hr, which 
was in between the formulations (IF2, IF5 and 
IF8) containing 8 mg per tablet and 
formulation (IF3, IF6 and IF9) having 12mg 
per tablet of different super-disintegrants. 
Combination of two approaches resulted in 
increase in dissolution rate. Among all the 
ODT formulations, IF11 released highest 
amount of drug release (98.54±2.9%) after 60 
min. This could be due to the synergistic effect 
of Ac-di-sol and CO2 released as soon as the 
tablet came in contact with water. This released 
CO2 accelerated the disintegration, which was 
in accordance with wetting and disintegration 
time (Table 3).  
 
Statistical analysis 
One-way ANOVA data showed that 
there were significant differences of in vitro drug 
release (P<0.05 level), when IF9 compared with 
batches from IF1 to IF8, between the batches 
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except IF9-IF3 and IF9-IF6. Among IF9-IF11, 
the significant differences observed between 
IF9 with IF10 and IF10 with IF11. The former 
results could be due to different types of super-
disintegration and their concentrations and the 




The evaluated physical parameters of 
formulation IF11 before and at the end of each 
months and in vitro drug release for optimized 
formulation IF11 before and after 3 months of 
stability study were presented in Table 4. From 
the mentioned data it was evident that there 
was no significant change in thickness, 
diameter, weight variation, hardness, content 




Fast dissolving tablets of IM were 
prepared in the present research work to 
increase its solubility and followed by the 
bioavailability. Super-disintegration (IF1-IF9), 
effervescence (IF10) and combination of the 
both approaches (IF11) were used to develop 
FDT. It was observed that, among all the 
super-disintegrants used, formulations having 
Ac-di-sol showed highest amount of drug 
release at same concentration as compared to 
Primogel and Kollidon. The formulation IF10 
released less amount of drug when compared 
to formulation containing super-disintegrants at 
higher concentration at 60min. Out of all the 
eleven formulations, IF11 showed highest 
amount (98.54±2.89) of drug release at the end 
of 1 hr. There were no significant changes in 
physical and in vitro data obtained after 3 
months of stability studies at accelerated 
condition. In vivo studies required to further 
ascertain its commercial viability.  
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